Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy.

Su, Tung-Hung; Hsu, Shih-Jer; Kao, Jia-Horng

Su, Tung-Hung; Hsu, Shih-Jer; Kao, Jia-Horng.

Afiliação

Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Hsu SJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: kaojh@ntu.edu.tw.

J Formos Med Assoc ; 121(2): 451-453, 2022 02.

Article em En | MEDLINE | ID: mdl-34454796

Assuntos

Antineoplásicos; Carcinoma Hepatocelular; Quimioembolização Terapêutica; Neoplasias Hepáticas; Antineoplásicos/uso terapêutico; Carcinoma Hepatocelular/tratamento farmacológico; Humanos; Neoplasias Hepáticas/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Revista: J Formos Med Assoc Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google